Guardant Health Statistics
Total Valuation
GH has a market cap or net worth of $3.76 billion. The enterprise value is $3.95 billion.
| Market Cap | 3.76B |
| Enterprise Value | 3.95B |
Important Dates
The next estimated earnings date is Thursday, August 1, 2024, after market close.
| Earnings Date | Aug 1, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
GH has 122.37 million shares outstanding. The number of shares has increased by 18.55% in one year.
| Shares Outstanding | 122.37M |
| Shares Change (YoY) | +18.55% |
| Shares Change (QoQ) | +2.64% |
| Owned by Insiders (%) | 4.58% |
| Owned by Institutions (%) | 95.63% |
| Float | 109.75M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.23 |
| Forward PS | 5.21 |
| PB Ratio | 55.11 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.55 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.95, with a Debt / Equity ratio of 19.32.
| Current Ratio | 5.95 |
| Quick Ratio | 5.52 |
| Debt / Equity | 19.32 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -177.38 |
Financial Efficiency
Return on equity (ROE) is -246.50% and return on invested capital (ROIC) is -38.22%.
| Return on Equity (ROE) | -246.50% |
| Return on Assets (ROA) | -25.90% |
| Return on Capital (ROIC) | -38.22% |
| Revenue Per Employee | $339,362 |
| Profits Per Employee | -$259,079 |
| Employee Count | 1,779 |
| Asset Turnover | 0.34 |
| Inventory Turnover | 4.37 |
Taxes
In the past 12 months, GH has paid $850,000 in taxes.
| Income Tax | 850,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -18.93% in the last 52 weeks. The beta is 1.13, so GH's price volatility has been higher than the market average.
| Beta (5Y) | 1.13 |
| 52-Week Price Change | -18.93% |
| 50-Day Moving Average | 27.88 |
| 200-Day Moving Average | 24.08 |
| Relative Strength Index (RSI) | 55.73 |
| Average Volume (20 Days) | 1,414,466 |
Short Selling Information
The latest short interest is 7.86 million, so 6.43% of the outstanding shares have been sold short.
| Short Interest | 7.86M |
| Short Previous Month | 7.63M |
| Short % of Shares Out | 6.43% |
| Short % of Float | 7.16% |
| Short Ratio (days to cover) | 3.56 |
Income Statement
In the last 12 months, GH had revenue of $603.73 million and -$460.90 million in losses. Loss per share was -$3.96.
| Revenue | 603.73M |
| Gross Profit | 364.45M |
| Operating Income | -530.35M |
| Pretax Income | -460.05M |
| Net Income | -460.90M |
| EBITDA | -414.22M |
| EBIT | -457.47M |
| Loss Per Share | -$3.96 |
Balance Sheet
The company has $1.13 billion in cash and $1.32 billion in debt, giving a net cash position of -$190.26 million or -$1.55 per share.
| Cash & Cash Equivalents | 1.13B |
| Total Debt | 1.32B |
| Net Cash | -190.26M |
| Net Cash Per Share | -$1.55 |
| Equity (Book Value) | 68.29M |
| Book Value Per Share | 0.56 |
| Working Capital | 1.09B |
Cash Flow
In the last 12 months, operating cash flow was -$280.82 million and capital expenditures -$19.90 million, giving a free cash flow of -$300.71 million.
| Operating Cash Flow | -280.82M |
| Capital Expenditures | -19.90M |
| Free Cash Flow | -300.71M |
| FCF Per Share | -$2.47 |
Margins
Gross margin is 60.37%, with operating and profit margins of -87.85% and -76.34%.
| Gross Margin | 60.37% |
| Operating Margin | -87.85% |
| Pretax Margin | -76.20% |
| Profit Margin | -76.34% |
| EBITDA Margin | -68.61% |
| EBIT Margin | -75.77% |
| FCF Margin | -49.81% |
Dividends & Yields
GH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -18.55% |
| Shareholder Yield | -18.55% |
| Earnings Yield | -12.25% |
| FCF Yield | -7.99% |
Analyst Forecast
The average price target for GH is $37.17, which is 20.88% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $37.17 |
| Price Target Difference | 20.88% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (5Y) | 20.11% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
GH has an Altman Z-Score of -0.24 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.24 |
| Piotroski F-Score | 4 |